Utility of estimated pulse wave velocity for assessing vascular stiffness: comparison of methods

  1. Stefan Möstl
  2. Fabian Hoffmann
  3. Jan-Niklas Hönemann
  4. Jose Ramon Alvero-Cruz
  5. Jörn Rittweger
  6. Jens Tank
  7. Jens Jordan  Is a corresponding author
  1. German Aerospace Center, Germany
  2. University Hospital Cologne, Germany
  3. University of Málaga, Spain

Abstract

Background: Pulse wave velocity independently predicts cardiovascular risk. Easy to use single cuff oscillometric methods are utilized in clinical practice to estimate pulse wave velocity. We applied the approach in master athletes to assess possible beneficial effects of lifelong exercise on vascular health. Furthermore, we compared single cuff measurements with a two-cuff method in another cohort.

Methods: We obtained single cuff upper arm oscillometric measurements thrice in 129 master athletes aged 35 to 86 years and estimated pulse wave velocity using the ArcSolver algorithm. We applied the same method in 24 healthy persons aged 24 to 55 years participating in a head down tilt bedrest study. In the latter group, we also obtained direct pulse wave velocity measurements using a thigh cuff.

Results: Estimated pulse velocity very highly correlated with age (R2 = 0.90) in master athletes. Estimated pulse wave velocity values were located on the same regression line like values obtained in participants of the head down tilt bed rest study. The modest correlation between estimated and measured PWV (r2 0.40; p<0.05) was attenuated after adjusting for age; the mean difference between pulse wave velocity measurements was 1 m/s.

Conclusion: Estimated pulse wave velocity mainly reflects the entered age rather than true vascular properties and, therefore, failed detecting beneficial effects of life long exercise.

Funding: The AGBRESA-Study was funded by the German Aerospace Center (DLR), the European Space Agency (ESA, contract number 4000113871/15/NL/PG) and the National Aeronautics and Space Administration (NASA, contract number 80JSC018P0078). FH received funding by the DLR and the German Federal Ministry of Economy and Technology, BMWi (50WB1816). SM, JT and JJ were supported by the Austrian Federal Ministry for Climate Action, Environment, Energy, Mobility, Innovation and Technology, BMK (SPACE4ALL Project, FFG No. 866761).

Data availability

As we obtained personal health data from human subjects, we cannot make their raw data publicly available. However, an interested researcher is able to access the original data by sending a project proposal to the corresponding author. This project proposal will be reviewed by the medical board of the DLR Institute of Aerospace Medicine. If the project is scientifically valuable, the committee decides to what extent the original data can be made available. Commercial research is excluded from this option. The syntax used for statistical analysis and the numerical data used to generate the figures are stored in Dryad: doi:10.5061/dryad.8931zcrsb#

The following data sets were generated

Article and author information

Author details

  1. Stefan Möstl

    Department of Cardiovascular Aerospace Medicine, German Aerospace Center, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4983-4754
  2. Fabian Hoffmann

    Department of Cardiology, University Hospital Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Jan-Niklas Hönemann

    Department of Cardiology, University Hospital Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Jose Ramon Alvero-Cruz

    Department of Human Physiology and Physical Sports Education, University of Málaga, Málaga, Spain
    Competing interests
    The authors declare that no competing interests exist.
  5. Jörn Rittweger

    Department of Cardiovascular Aerospace Medicine, German Aerospace Center, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Jens Tank

    Department of Cardiovascular Aerospace Medicine, German Aerospace Center, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Jens Jordan

    Department of Cardiovascular Aerospace Medicine, German Aerospace Center, Cologne, Germany
    For correspondence
    Jens.Jordan@dlr.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4518-0706

Funding

German Federal Ministry of Economy and Technology (50WB1816)

  • Fabian Hoffmann

Austrian Federal Ministry for Climate Action, Environment, Energy, Mobility, Innovation and Technology (FFG No. 866761)

  • Stefan Möstl
  • Jens Tank
  • Jens Jordan

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: All subjects provided informed consent and consent to publish before enrollment. The bedrest study as well as the study in master athletes were approved by the Northrine-Medical-Association (Ärztekammer Nordrhein, 2018143 and 2018171) ethics committee and registered at the German Clinical Trial Register (DRKS00015677 and DRKS00015172)

Copyright

© 2022, Möstl et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 541
    views
  • 102
    downloads
  • 4
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Stefan Möstl
  2. Fabian Hoffmann
  3. Jan-Niklas Hönemann
  4. Jose Ramon Alvero-Cruz
  5. Jörn Rittweger
  6. Jens Tank
  7. Jens Jordan
(2022)
Utility of estimated pulse wave velocity for assessing vascular stiffness: comparison of methods
eLife 11:e73428.
https://doi.org/10.7554/eLife.73428

Share this article

https://doi.org/10.7554/eLife.73428

Further reading

    1. Medicine
    Paul Horn, Jenny Norlin ... Philip N Newsome
    Research Article

    Gremlin-1 has been implicated in liver fibrosis in metabolic dysfunction-associated steatohepatitis (MASH) via inhibition of bone morphogenetic protein (BMP) signalling and has thereby been identified as a potential therapeutic target. Using rat in vivo and human in vitro and ex vivo model systems of MASH fibrosis, we show that neutralisation of Gremlin-1 activity with monoclonal therapeutic antibodies does not reduce liver inflammation or liver fibrosis. Still, Gremlin-1 was upregulated in human and rat MASH fibrosis, but expression was restricted to a small subpopulation of COL3A1/THY1+ myofibroblasts. Lentiviral overexpression of Gremlin-1 in LX-2 cells and primary hepatic stellate cells led to changes in BMP-related gene expression, which did not translate to increased fibrogenesis. Furthermore, we show that Gremlin-1 binds to heparin with high affinity, which prevents Gremlin-1 from entering systemic circulation, prohibiting Gremlin-1-mediated organ crosstalk. Overall, our findings suggest a redundant role for Gremlin-1 in the pathogenesis of liver fibrosis, which is unamenable to therapeutic targeting.

    1. Medicine
    2. Neuroscience
    Jie Zhang, Jianguo Cheng
    Insight

    A complex extracted from the amniotic membrane in humans reduces post-surgical pain in mice by directly inhibiting pain-sensing neurons.